Finance

Female contraceptive market size to grow by USD 5,142.22 million: Personal products industry is the parent market


NEW YORK, Dec. 10, 2022 /PRNewswire/ — The global female contraceptive market has been categorized as a part of the global personal products market. The parent market, the global personal products market, covers products and companies engaged in the research and development (R&D) and production of personal and beauty care products, such as cosmetics and perfumes. The scope of this market also includes personalized gifts, sleep masks, sex toys, hair wigs and extensions, and polarized sunglasses markets.

Technavio has announced its latest market research report titled Global Female Contraceptive Market 2023-2027

Technavio has announced its latest market research report titled Global Female Contraceptive Market 2023-2027

The female contraceptive market size is forecasted to grow by USD 5,142.22 million from 2022 to 2026. The market is estimated to grow at a CAGR of 5.32% during the forecast period, according to Technavio. Download a sample

Female contraceptive market 2023-2027: Scope

The female contraceptive market report covers the following areas:

Female contraceptive market 2023-2027: Vendor landscape

The global female contraceptive market was fragmented in 2022, with the presence of a large number of international and local players. International players offer a wide range of female contraceptives, while local vendors mainly cater to the demands of consumers with particular preferences. This, in turn, has resulted in intense competition in the market. In addition, various players are engaging in continuous R&D to improve the quality of contraceptives in terms of design and materials, which is further intensifying the competition.

AbbVie Inc., Afaxys Pharma LLC, Agile Therapeutics Inc., Amgen Inc., Ansell Ltd., Bayer AG, CooperSurgical Inc., Cupid Ltd., Exeltis USA Inc., Johnson & Johnson, Mayer Laboratories Inc., Medisafe Distribution Inc., Merck & Co. Inc., Mylan NV, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veru Inc. are among some of the major market participants.

Female contraceptive market 2023-2027: Competitive analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies, growth strategies, product innovations, new product launches, investments, growth in market share, among others. Buy the report

Female contraceptive market 2023-2027: Segmentation

The offline segment will account for the largest share of the market’s growth during the forecast period. This segment includes merchandisers, drugstores, non-commercial outlets, and others. The growth of merchandisers will be steady during the forecast period due to factors such as rising awareness about female contraceptive products. The preference for drugstores is growing at a significant rate due to the increasing customer confidence in products sold through drugstores or pharmacies in terms of quality, usefulness, safety, and standards.

North America is estimated to account for 38% of the market’s growth during the forecast period. The growth of the market in this region is attributed to factors such as high product penetration and availability. The availability of advanced female contraceptive products such as IUDs is also driving the regional market’s growth. The demand for these products is increasing, as they are considered effective in preventing pregnancies and are cost-effective.

To gain further insights about various segments, Request a PDF sample

What are the key data covered in this female contraceptive market report?

  • CAGR of the market during the forecast period

  • Detailed information on factors that will drive the growth of the female contraceptive market between 2023 and 2027

  • Precise estimation of the size of the female contraceptive market and its contribution to the parent market

  • Accurate predictions about upcoming trends and changes in consumer behavior

  • Growth of the female contraceptive market across APAC, North America, Europe, Middle East and Africa, and South America

  • Thorough analysis of the market’s competitive landscape and detailed information about vendors

  • Comprehensive analysis of factors that will challenge the growth of female contraceptive market vendors

Subscribe to our “Basic Plan” billed annually at USD 5000, which enables you to download 5 reports and view 100 reports every month

Related reports:

Feminine hygiene products market by distribution channel, product, and geography – Forecast and analysis 2023-2027: The feminine hygiene products market size is expected to increase by USD 11,407.53 million from 2022 to 2027. This report extensively covers market segmentation by distribution channel (offline and online), product (sanitary napkins, tampons, pantyliners, menstrual cups, and feminine hygiene wash), and geography (Europe, North America, APAC, South America, and Middle East and Africa).

Feminine hygiene wash market by distribution channel, end-user, and geography – Forecast and analysis 2023-2027: The feminine hygiene wash market size is expected to increase by USD 121.55 million from 2022 to 2027. This market is segmented by distribution channel (offline and online), end-user (female teenagers and female adults), and geography (APAC, North America, Europe, South America, and Middle East and Africa).

Female Contraceptive Market Scope

Report Coverage

Details

Page number

168

Base year

2022

Historical year

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 5.32%

Market growth 2023-2027

USD 5,142.22 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

4.2

Regional analysis

North America, APAC, Europe, South America, and Middle East and Africa

Performing market contribution

North America at 38%

Key consumer countries

US, Canada, China, Japan, and France

Competitive landscape

Leading companies, market positioning of vendors, competitive strategies, and industry risks

Companies profiled

AbbVie Inc., Afaxys Pharma LLC, Agile Therapeutics Inc., Amgen Inc., Ansell Ltd., Bayer AG, CooperSurgical Inc., Cupid Ltd., Exeltis USA Inc., Johnson & Johnson, Mayer Laboratories Inc., Medisafe Distribution Inc., Merck & Co. Inc., Mylan NV, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veru Inc.

Market dynamics

Parent market analysis; market growth inducers and obstacles; fast-growing and slow-growing segment analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio’s consumer staples market reports

Table of contents:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Distribution Channel

7 Market Segmentation by Product

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Global Female Contraceptive Market 2023-2027

Global Female Contraceptive Market 2023-2027

Cision

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/female-contraceptive-market-size-to-grow-by-usd-5-142-22-million-personal-products-industry-is-the-parent-market–technavio-301699044.html

SOURCE Technavio



Source link

Leave a Response